244 related articles for article (PubMed ID: 28967881)
1. Nuclear topology modulates the mutational landscapes of cancer genomes.
Smith KS; Liu LL; Ganesan S; Michor F; De S
Nat Struct Mol Biol; 2017 Nov; 24(11):1000-1006. PubMed ID: 28967881
[TBL] [Abstract][Full Text] [Related]
2. DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes.
Liu L; De S; Michor F
Nat Commun; 2013; 4():1502. PubMed ID: 23422670
[TBL] [Abstract][Full Text] [Related]
3. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
Haradhvala NJ; Polak P; Stojanov P; Covington KR; Shinbrot E; Hess JM; Rheinbay E; Kim J; Maruvka YE; Braunstein LZ; Kamburov A; Hanawalt PC; Wheeler DA; Koren A; Lawrence MS; Getz G
Cell; 2016 Jan; 164(3):538-49. PubMed ID: 26806129
[TBL] [Abstract][Full Text] [Related]
4. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate.
Vardi-Yaacov O; Yaacov A; Rosenberg S; Simon I
Sci Rep; 2023 Aug; 13(1):13143. PubMed ID: 37573368
[TBL] [Abstract][Full Text] [Related]
5. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
Singh VK; Rastogi A; Hu X; Wang Y; De S
Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
[TBL] [Abstract][Full Text] [Related]
6. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
7. Sequence dependencies and mutation rates of localized mutational processes in cancer.
Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
Phillips DH
DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure.
Akdemir KC; Le VT; Kim JM; Killcoyne S; King DA; Lin YP; Tian Y; Inoue A; Amin SB; Robinson FS; Nimmakayalu M; Herrera RE; Lynn EJ; Chan K; Seth S; Klimczak LJ; Gerstung M; Gordenin DA; O'Brien J; Li L; Deribe YL; Verhaak RG; Campbell PJ; Fitzgerald R; Morrison AJ; Dixon JR; Andrew Futreal P
Nat Genet; 2020 Nov; 52(11):1178-1188. PubMed ID: 33020667
[TBL] [Abstract][Full Text] [Related]
10. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.
Yaacov A; Vardi O; Blumenfeld B; Greenberg A; Massey DJ; Koren A; Adar S; Simon I; Rosenberg S
Cancer Res; 2021 Dec; 81(24):6106-6116. PubMed ID: 34702725
[TBL] [Abstract][Full Text] [Related]
11. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
12. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
[TBL] [Abstract][Full Text] [Related]
13. The topography of mutational processes in breast cancer genomes.
Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
[TBL] [Abstract][Full Text] [Related]
14. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
15. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes.
De S; Michor F
Nat Biotechnol; 2011 Nov; 29(12):1103-8. PubMed ID: 22101487
[TBL] [Abstract][Full Text] [Related]
16. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
[TBL] [Abstract][Full Text] [Related]
17. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying mutational signatures in human cancers.
Helleday T; Eshtad S; Nik-Zainal S
Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
[TBL] [Abstract][Full Text] [Related]
19. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
